Clinical Trial

The Efficacy of High-Power Laser Therapy in Meralgia Paresthetica

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 13, 2026 (before its estimated July 5, 2026 completion). Its status may not reflect the trial's current state.
Summary
The management of MP typically follows a conservative pathway, encompassing patient education, lifestyle modifications (e.g., avoidance of tight garments, weight loss), pharmacotherapy (such as neuropathic pain agents or corticosteroid injections), and physical therapy. However, evidence supporting the efficacy of these interventions is largely anecdotal or derived from low-quality studies, and a substantial proportion of patients experience persistent symptoms refractory to standard care. Therefore, the primary objective of this randomized, sham-controlled, assessor-blinded study is to investigate the efficacy of HPLT as an adjunct to standard conservative care on pain intensity, sensory symptoms, and functional capacity in patients with chronic Meralgia Paresthetica. The investigators hypothesize that patients receiving active HPLT will demonstrate significantly greater improvements in these outcomes compared to those receiving a sham laser procedure
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-03.
Status change: Not Yet Recruiting → Recruiting 2026-01-12
Trial Details
NCT Number NCT07328360
Lead Sponsor Uşak University
Collaborators: Balikesir University
Conditions Meralgia Paresthetica
Enrollment 50 participants
Start Date 2026-01-12
Primary Completion 2026-07-05 (estimated)
Study Completion 2026-08-05 (estimated)
Updated on ClinicalTrials.gov 2026-01-13